PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT 2.1 Preface 2.2 Preface 2.3 Currency conversion rates for US$ PART 03: MARKET LANDSCAPE Market ecosystem Market characteristics Market segmentation analysis PART 04: MARKET SIZING Market definition Market sizing 2018 Market size and forecast 2018-2023 PART 05: FIVE FORCES ANALYSIS Bargaining power of buyers Bargaining power of suppliers Threat of new entrants Threat of substitutes Threat of rivalry Market condition PART 06: PIPELINE PART 07: MARKET SEGMENTATION BY PRODUCT Market segmentation by product Comparison by product Local antibiotics - Market size and forecast 2018-2023 Systemic antibiotics - Market size and forecast 2018-2023 Market opportunity by product PART 08: CUSTOMER LANDSCAPE PART 09: GEOGRAPHIC LANDSCAPE Geographic segmentation Geographic comparison North America - Market size and forecast 2018-2023 Europe - Market size and forecast 2018-2023 Asia - Market size and forecast 2018-2023 ROW - Market size and forecast 2018-2023 Key leading countries Market opportunity PART 10: DECISION FRAMEWORK PART 11: DRIVERS AND CHALLENGES Market drivers Market challenges PART 12: MARKET TRENDS PART 13: VENDOR LANDSCAPE Overview Landscape disruption Competitive scenario PART 14: VENDOR ANALYSIS Vendors covered Vendor classification Market positioning of vendors 3M Co. Bausch Health Companies, Inc. Den-Mat Holdings LLC Kaken Pharmaceuticals Co. Ltd. Teva Pharmaceutical Industries Ltd. PART 15: APPENDIX Research methodology List of abbreviations Definition of market positioning of vendors PART 16: EXPLORE TECHNAVIO Exhibit 01: Global oral hygiene products market Exhibit 02: Segments of global oral hygiene products market Exhibit 03: Market characteristics Exhibit 04: Market segments Exhibit 05: Market definition - Inclusions and exclusions checklist Exhibit 06: Market size 2018 Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions) Exhibit 08: Global market: Year-over-year growth 2019-2023 (%) Exhibit 09: Five forces analysis 2018 Exhibit 10: Five forces analysis 2023 Exhibit 11: Bargaining power of buyers Exhibit 12: Bargaining power of suppliers Exhibit 13: Threat of new entrants Exhibit 14: Threat of substitutes Exhibit 15: Threat of rivalry Exhibit 16: Market condition - Five forces 2018 Exhibit 17: Pipeline landscape for periodontal diseases Exhibit 18: Some of the key clinical trials for periodontal diseases Exhibit 19: Product - Market share 2018-2023 (%) Exhibit 20: Comparison by product Exhibit 21: Local antibiotics - Market size and forecast 2018-2023 ($ millions) Exhibit 22: Local antibiotics - Year-over-year growth 2019-2023 (%) Exhibit 23: Systemic antibiotics - Market size and forecast 2018-2023 ($ millions) Exhibit 24: Systemic antibiotics - Year-over-year growth 2019-2023 (%) Exhibit 25: Market opportunity by product Exhibit 26: Customer landscape Exhibit 27: Market share by geography 2018-2023 (%) Exhibit 28: Geographic comparison Exhibit 29: North America - Market size and forecast 2018-2023 ($ millions) Exhibit 30: North America - Year-over-year growth 2019-2023 (%) Exhibit 31: Top 3 countries in North America Exhibit 32: Europe - Market size and forecast 2018-2023 ($ millions) Exhibit 33: Europe - Year-over-year growth 2019-2023 (%) Exhibit 34: Top 3 countries in Europe Exhibit 35: Asia - Market size and forecast 2018-2023 ($ millions) Exhibit 36: Asia - Year-over-year growth 2019-2023 (%) Exhibit 37: Top 3 countries in Asia Exhibit 38: ROW - Market size and forecast 2018-2023 ($ millions) Exhibit 39: ROW - Year-over-year growth 2019-2023 (%) Exhibit 40: Top 3 countries in ROW Exhibit 41: Key leading countries Exhibit 42: Market opportunity Exhibit 43: Risk factors for periodontal diseases Exhibit 44: Impact of drivers and challenges Exhibit 45: Percent of periodontal disease with age Exhibit 46: Vendor landscape Exhibit 47: Landscape disruption Exhibit 48: Vendors covered Exhibit 49: Vendor classification Exhibit 50: Market positioning of vendors Exhibit 51: 3M Co. - Vendor overview Exhibit 52: 3M Co. - Business segments Exhibit 53: 3M Co. - Organizational developments Exhibit 54: 3M Co. - Geographic focus Exhibit 55: 3M Co. - Segment focus Exhibit 56: 3M Co. - Key offerings Exhibit 57: 3M Co. - Key customers Exhibit 58: Bausch Health Companies Inc. - Vendor overview Exhibit 59: Bausch Health Companies Inc. - Product segments Exhibit 60: Bausch Health Companies Inc. - Organizational developments Exhibit 61: Bausch Health Companies Inc. - Geographic focus Exhibit 62: Bausch Health Companies Inc. - Segment focus Exhibit 63: Bausch Health Companies Inc. - Key offerings Exhibit 64: Bausch Health Companies Inc. - Key customers Exhibit 65: Den-Mat Holdings LLC - Vendor overview Exhibit 66: Den-Mat Holdings LLC - Business segments Exhibit 67: Den-Mat Holdings LLC - Organizational developments Exhibit 68: Den-Mat Holdings LLC - Key offerings Exhibit 69: Den-Mat Holdings LLC - Key customers Exhibit 70: Kaken Pharmaceuticals Co. Ltd. - Vendor overview Exhibit 71: Kaken Pharmaceuticals Co. Ltd. - Business segments Exhibit 72: Kaken Pharmaceuticals Co. Ltd. - Organizational developments Exhibit 73: Kaken Pharmaceuticals Co. Ltd. - Segment focus Exhibit 74: Kaken Pharmaceuticals Co. Ltd. - Key offerings Exhibit 75: Kaken Pharmaceuticals Co. Ltd. - Key customers Exhibit 76: Teva Pharmaceutical Industries Ltd. - Vendor overview Exhibit 77: Teva Pharmaceutical Industries Ltd. - Business segments Exhibit 78: Teva Pharmaceutical Industries Ltd. - Organizational developments Exhibit 79: Teva Pharmaceutical Industries Ltd. - Geographic focus Exhibit 80: Teva Pharmaceutical Industries Ltd. - Segment focus Exhibit 81: Teva Pharmaceutical Industries Ltd. - Key offerings Exhibit 82: Teva Pharmaceutical Industries Ltd. - Key customers Exhibit 83: Validation techniques employed for market sizing Exhibit 84: Definition of market positioning of vendors

3M Co. Bausch Health Companies Inc. Den-Mat Holdings LLC Kaken Pharmaceuticals Co. Ltd. Teva Pharmaceutical Industries Ltd.